Cellectar Biosciences (CLRB) Reports Q3 Loss of $0.25
Cellectar Biosciences (NASDAQ: CLRB) reported Q3 EPS of ($0.25), versus $0.06 reported last year.
For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.
Cellectar Biosciences (NASDAQ: CLRB) reported Q3 EPS of ($0.25), versus $0.06 reported last year.
For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.